GENEVA, July 1 -- ENGIMMUNE THERAPEUTICS AG filed a patent application (EP2025/086360) for “MULTIFUNCTIONAL MOLECULES COMPRISING SOLUBLE TCR FRAGMENTS AND USES THEREOF”. With publication no. WO/2026/125496, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 14/705
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....